Dr. Elena Herrera-Carrillo’s team at Amsterdam UMC, with Yuanling Bao, Zhenghao Yu, Pascal Kroon, successfully eliminate diverse HIV strains using CRISPR/Cas9 in multiple cell types, marking a significant advancement in medical research. “Striving for an inclusive ‘HIV cure for all’ that can inactivate diverse HIV strains across various cellular contexts,” the study authors have said.

​Dr. Elena Herrera-Carrillo’s team at Amsterdam UMC, with Yuanling Bao, Zhenghao Yu, Pascal Kroon, successfully eliminate diverse HIV strains using CRISPR/Cas9 in multiple cell types, marking a significant advancement in medical research. “Striving for an inclusive ‘HIV cure for all’ that can inactivate diverse HIV strains across various cellular contexts,” the study authors have said. 

​ 



Leave a Reply

Your email address will not be published. Required fields are marked *

Search

About

Lorem Ipsum has been the industrys standard dummy text ever since the 1500s, when an unknown prmontserrat took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industrys standard dummy text ever since the 1500s, when an unknown prmontserrat took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

Gallery